NCT06464614 2024-06-18
Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.
The First Affiliated Hospital of Henan University of Science and Technology
Phase 2 Not yet recruiting
Clinical Trials
5 trialsNCT03787251 2022-04-19
A Study of Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With Apatinib
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Withdrawn
NCT03274011 2021-01-26
Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Fudan University
Phase 2 Completed
NCT02544737 2016-08-26
Apatinib for Metastatic Esophageal Cancer.
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT02683655 2016-02-17
Study of Apatinib in Metastatic Esophageal Cancer
Huai'an First People's Hospital
Phase 2 Unknown